Walleye Trading
PTCT icon

Walleye Trading’s PTC Therapeutics PTCT Stock Holding History

Walleye Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,100
Closed -$615K – 4585
2025
Q4 		$615K Buy
8,100
+4,900
+153% +$356K ﹤0.01% 2690
2025
Q3 		$196K Buy
+3,200
New +$167K ﹤0.01% 3382
2023
Q2 		– Sell
-5,300
Closed -$257K – 5105
2023
Q1 		$257K Buy
+5,300
New +$242K ﹤0.01% 3335
2021
Q4 		– Sell
-29,100
Closed -$1.08M – 5762
2021
Q3 		$1.08M Buy
29,100
+19,300
+197% +$793K ﹤0.01% 2122
2021
Q2 		$414K Buy
9,800
+8,500
+654% +$364K ﹤0.01% 3116
2021
Q1 		$62K Buy
+1,300
New +$77.2K ﹤0.01% 4270
2020
Q3 		– Sell
-2,500
Closed -$127K – 4509
2020
Q2 		$127K Sell
2,500
-7,600
-75% -$373K ﹤0.01% 3372
2020
Q1 		$451K Sell
10,100
-2,300
-19% -$116K ﹤0.01% 1956
2019
Q4 		$596K Buy
12,400
+9,800
+377% +$416K ﹤0.01% 2260
2019
Q3 		$88K Buy
2,600
+600
+30% +$26.1K ﹤0.01% 3379
2019
Q2 		$90K Buy
2,000
+700
+54% +$27.6K ﹤0.01% 3348
2019
Q1 		$49K Sell
1,300
-2,900
-69% -$97.4K ﹤0.01% 3722
2018
Q4 		$144K Buy
+4,200
New +$151K ﹤0.01% 3665

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Walleye Trading's PTCT Position: Q1 2026 in Review

Walleye Trading sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 15,926 shares — an estimated $1.21M sold.

Walleye Trading first reported a position in PTCT in Q1 2015 and held it in 11 quarters. The position peaked at $1.21M in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Walleye Trading reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 15,926 PTC Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Walleye Trading first reported a position in PTC Therapeutics in Q1 2015 and held it in 11 quarters.
  • Walleye Trading's PTC Therapeutics position peaked at $1.21M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.